<DOC>
	<DOCNO>NCT01315496</DOCNO>
	<brief_summary>This study determine whether intravenous application ' Ⅳ-Globulin S inj . ( Human Immunoglobulin G ) ' reduce mortality patient severe sepsis septic shock .</brief_summary>
	<brief_title>GCIV Adjuvant Therapy Community-Acquired Severe Sepsis Septic Shock</brief_title>
	<detailed_description>A Placebo-controlled , Randomized , Double-blind , Multi-center , Phase 3 Study Evaluate Efficacy Safety Intravenous Administration 'IV-Globulin S inj . ( Human Immunoglobulin G ) ' Adjuvant Therapy Adult Subjects Community-Acquired Severe Sepsis Septic Shock .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>Patients severe sepsis septic shock , follow criterion satisfy . 1 . Age ≥ 18 year 2 . Proved suspected infection least one site pneumonia urinary tract infection intraabdominal infection primary bloodstream infection skin soft tissue infection 3 . Three follow core temperature ≥ 38° C ≤ 36° C heart rate ≥ 90 beats/min respiratory rate ≥ 20 breaths/min PaCO2 ≤ 32 mmHg use mechanical ventilation acute process white blood cell count ≥ 12000/mm3 ≤ 4000/ mm3 immature neutrophil &gt; 10 % 4 . Acute organ failure one follow kidney respiratory system blood system metabolic system circulatory system 5 . APACHE score ≥ 20 ≤ 29 6 . Patient treatment GCIV ICU within least 48 hour 7 . Informed consent 1 . Pregnant breastfeed woman 2. weight &gt; 100kg 3. discharged hospital least 14 day prior new admission 4 . Transferred another hospital stay 48 hour 5. allergy shock IVIG 6 . Treated IVIG within 12 week immediately precede enrolment study 7 . IgA deficiency 8 . Hypernatremia hyperhydration 9 . Proved suspected HIV AIDS patient ( CD4+ &lt; 200mL ) 10 . Current participation study within last 4 week 11 . Do resuscitate ( DNR ) status 12 . Patient 's death consider imminent due coexist disease 13. physician decision exclude patient protocol 14 . Immunocompromised patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Human Immunoglobulin G</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Septic shock</keyword>
</DOC>